Evidence map›Paper›PMID 39339287›Full record

ArticleMolecules (Basel, Switzerland)2024

Secobutanolides Isolated from

Hye Jin Yang, Young-Sang Koh, MinKyun Na, Wei Li

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hye Jin YangCollege of Pharmacy, Chungnam National University, Daejeon 305-764, Republic of Korea.ORCID 0000-0002-8876-0201
Young-Sang KohSchool of Medicine and Brain Korea 21 PLUS Program, Institute of Medical Science, Jeju National University, Jeju 690-756, Republic of Korea.ORCID 0000-0003-1467-3655
MinKyun NaCollege of Pharmacy, Chungnam National University, Daejeon 305-764, Republic of Korea.ORCID 0000-0002-4865-6506
Wei LiKorean Medicine (KM) Application Center, Korea Institute of Oriental Medicine, Daegu 41062, Republic of Korea.ORCID 0000-0001-7272-7290

Funding

Ministry of Education, Science and Technology (MEST), Republic of Korea KSN2411011
6 · The paper itself

Abstract

In this study, a new secobutanolide, named secosubamolide B (

Indexed as

Anti-Inflammatory AgentsLinderaLipopolysaccharidesPlant StemsAnimalsDendritic CellsInterleukin-12 Subunit p40Interleukin-6MiceMolecular StructurePlant ExtractsAnti-Inflammatory AgentsInterleukin-12 Subunit p40Interleukin-6LipopolysaccharidesPlant Extractsanti-inflammatory activityLauraceaeLindera obtusilobasecobutanolide

Identifiers

PMID39339287
PMCPMC11434359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.